Jul 27, 2020

MP Biomedicals and A*Star Singapore Co-develop Rapid Antibody Point-of-Care Test Kit for SARS-CoV-2

ASSURE® SARS-CoV-2 IgG/IgM Rapid Test kit detects antibodies produced by the human immune system in response to exposure to COVID-19.

Jun 05, 2020

FastPrep-24™ Classic used in COVID-19 Vaccine Development

MP Biomedicals FastPrep® Instruments help expedite COVID-19 current vaccine research with INOVIO Pharmaceuticals, University of Oxford and CSIRO in Australia.

MP Biomedicals is proud to see the FastPrep-24 Classic has been instrumental in SARS-CoV-2 therapeutic research. INOVIO Pharmaceuticals, together with University of Oxford and researchers at Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia, were featured on 9 News Australia showcasing their COVID-19 vaccine development.

Mar 03, 2020

MP Biomedicals Announces Launch of SARS-CoV-2 Products

MP Biomedicals, a division of Valiant Co., Ltd., is stepping in to support scientists worldwide in understanding SARS-CoV-2 and discovering solutions to combat COVID-19 by launching several new monoclonal antibodies and recombinant antigens.

Mar 06, 2019

Article in Genetic Engineering & Biotechnology, “High-Performance Density Gradient Media for Purification of Leukocytes from Blood”.

MP Bio describes formulations that isolate mononuclear and polymorphonuclear leukocytes with high yield and viability using Lymphocyte Separation Medium (LSM™), LymphoSep™, and Mono-Poly™ Resolving Medium.

Jan 23, 2018

MP Biomedicals Announces New Dedicated Clean Rooms for Animal and Non-Animal Products

MP Biomedicals Announces New Dedicated Clean Rooms for Animal and Non-Animal Products

MP Biomedicals, LLC announces the installation of dedicated cleanrooms for animal origin (AO) and non-animal origin (NAO) products in their Solon, Ohio, USA facility. The addition of the ISO Class 6 clean rooms continues an ongoing initiative to meet the stringent quality control and regulatory compliance standards vital for biopharmaceutical and bioprocessing applications.

Aug 23, 2017

MP Biomedicals Are Approved to Export Bovine Blood Products to China

MP Biomedicals has been approved for exports of bovine blood proteins into China. This approval, granted last month to 16 companies by the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (AQSIQ) allows MP Biomedicals to export its entire range of bovine blood proteins into China. These products are used in the Life Science market for the manufacture of therapeutic monoclonal antibodies, vaccines, infectious disease media, diagnostic kits, cell culture media and other research purposes.

Aug 16, 2017

MP Biomedicals, LLC Agrees to Sell Rapid Diagnostics Division

MP Biomedicals LLC, a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, has agreed to sell the assets of their Rapid Diagnostics division to LumiQuick Diagnostics Inc., a manufacturer of high quality point of care tests and other immunoassay kits.

Mar 18, 2016

Aquisition of MP Biomedicals by Valiant Co. Ltd

We are pleased to announce MP Biomedicals is now part of the Valiant Family, the acquisition of 100% membership interest of MP Biomedicals was completed on March 18. Valiant is ideally suitable to support MP's business with experienced R & D team, rich manufacturing capacity and abundant funding.

Apr 02, 2009

First large scale cryogenic lysis adapter for FastPrep-24 now available!

MP Biomedicals LLC, manufacturer of the leading sample preparation system, FastPrep-24 has announced the availability of a new cryogenic lysis adapter, TeenCoolPrep. The adapter is designed for cryogenic lysis of medium to large scale RNA preparation from difficult to lyse samples. The adapter is the first cryogenic grinding, homogenization and lysis adapter to be used specifically for standard 15ml tubes.